MCF-7 breast cancer cells transfected with protein kinase C-α exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype

Journal of Clinical Investigation

Volumn 95, Issue 4, 1995, Pages 1906-1915

  Ways, D Kirk ^a   Kukoly, Cynthia A ^a   DeVente, James ^a   Hooker, Jerry L ^a   Bryant, Winifred O ^a   Posekany, Karla J ^a   Fletcher, Donald J ^a   Cook, Paul P ^a   Parker, Peter J ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

anchorage independent; estrogen receptor; PKC isoforms; tumorigenicity; vimentin

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN KINASE C;

ARTICLE; BREAST CANCER; CANCER INVASION; CARCINOGENICITY; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL;

EID: 0028903545     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI117872     Document Type: Article

References (42)

1. Nishizuka, Y. 1988. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (Lond.). 334:661-665.
2. Parker, P., G. Kour, R. Marais, F. Mitchell, C. Pears, S. Stabel, and C. Webster. 1989. Protein kinase C: a family affair. Mol. Cell. Endocrinol. 65:1-11.
3. O'Brian, C., V. Vogel, S. Singletary, and E. Ward. 1989. Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res. 49:3215-3217.
4. 2+-dependent protein kinase of human mammary carcinoma cells: inverse relationships to estrogen receptors. Int. J. Cancer. 40:344-348.
5. Lee, S., J. Karaszkiewicz, and W. Anderson. 1992. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res. 52:3750-3759.
6. Fabbro, D., R. Regazzi, S. Costa, C. Borner, and U. Eppenberger. 1986. Protein kinase C desensitization by phorbol esters and its impact on growth of human breast cancer cells. Biochem. Biophys. Res. Commun. 135:65-73.
7. Issandou, M., F. Bayard, and J. Darbon. 1988. Inhibition of MCF-7 cell growth by 12-0-tetradecanoylphorbol-13-acetate and 1,2 dioctanoyl-SN-glycerol: distinct effects on protein kinase C activity. Cancer Res. 48:6943-6950.
8. Kennedy, M., L. Presligiacoma, G. Tyler, W. May, and N. Davidson. 1992. Differentiation effects of bryostatin 1 and phorbol ester on human breast cancer cell lines. Cancer Res. 52:1278-1283.
9. Valette, A., N. Gas, F. Roubinet, M. Dupont, and F. Bayard. 1987. Influence of 12-0-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events. Cancer Res. 47:1615-1620.
10. Seynaeve, C., M. Stetler-Stevenson, S. Sebers, G. Kaur, E. Sausville, and P. Worland. 1993. Cell cycle arrest and growth inhibition by the protein kinase antagonist UNC-01 in human breast carcinoma cells. Cancer Res. 53:2081-2086.
11. Pears, C., G. Kour, C. House, B. Kemp, and P. Parker. 1990. Mutagenesis of the pseudosubstrate site of protein kinase C leads to activation. Eur. J. Biochem. 194:89-94.
12. McNeall, J., A. Sanchez, P. Gray, C. Chesterman, and M. Sleigh. 1989. Hyperinducible gene expression from a metallothionein promoter containing additional metal-responsive elements. Gene (Amst.). 78:81-88.
13. Ways, D., B. Messer, T. Garris, W. Qin, P. Cook, and P. Parker. 1992. Modulation of protein kinase C ∈ by phorbol esters in the monoblastoid U937 cell. Cancer Res. 52:5604-5609.
14. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. 72:248-254.
15. Ways, D., P. Cook, C. Webster, and P. Parker. 1992. Effect of phorbol esters on PKC-ζ. J. Biol. Chem. 267:4799-4805.
16. Yasuda, I., A. Kishimoto, S. Tanaka, M. Tominaga, A. Sakurai, and Y. Nishizuka. 1990. A synthetic peptide substrate for selective assay of protein kinase C. Biochem. Biophys. Res. Commun. 166:1220-1227.
17. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
18. McCubrey, J., L. Steelman, G. Sandlin, R. Riddle, and D. Ways. 1990. Effects of phorbol esters on an interleukin-3-dependent cell line. Blood. 76:63-72.
19. Klein-Hitpass, L., M. Schorpp, V. Wagner, and G. Ryffel. 1986. An estrogen-responsive element derived from the 5′ flanking region of Xenopus vitellogenin A2 gene functions in transfected human cells. Cell. 46:1053-1061.
20. Heuijerjans, J., F. Pieper, F. Ramaekers, L. Timmermans, H. Kuijpers, H. Bloemendal, and W. Venrooij. 1989. Association of mRNA and elF-2α with the cytoskeleton in cells lacking vimentin. Exp. Cell Res. 181:317-330.
21. Raymond, W., and A. Leong. 1989. Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J. Pathol. 157:299-306.
22. Raymond, W., and A. Leong. 1989. Vimentin: a new prognostic parameter in breast carcinoma? J. Pathol. 158:107-114.
23. Rio, M., J. Bellocq, B. Gairard, U. Rasmussen, A. Krust, C. Keohl, H. Calderoli, V. Schiff, R. Renaud, and P. Chambon. 1987. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERB Z. Proc. Natl. Acad. Sci. USA 84:9243-9247.
24. Westley, B., and H. Rochefort. 1980. A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell. 20:353-362.
25. Muss, H., and T. Kute. 1982. Flow cytometry in the management of breast cancer. In High-Risk Breast Cancer: Diagnosis. J. Ragaz and I. Ariel, editors. Springer-Verlag, Berlin. 103-119.
26. Kurebayashi, J., S. McLeskey, M. Johnson, M. Lippman, R. Dickson, and F. Kern. 1993 Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor-4 and LacZ. Cancer Res. 53:2178-2187.
27. Bae, S., G. Arand, H. Azzam, P. Pavasant, J. Torri, T. Frandsen, and E. Thompson 1993. Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res. Treat. 24:241-255.
28. Knight, W., R. Livingston, E. Gregory, and W. McGuire. 1977. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 37:4669-4671.
29. Rochefort, H. 1990. Cathepsin D in breast cancer. Breast Cancer Res. Treat. 16:3-13.
30. Johnson, M., J. Torri, M. Lippman, and R. Dickson. 1993. The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res. 53:873-877.
31. Ree, A., B. Landmark, S. Walaas, H. Lahooti, L. Eikvar, W. Eskild, and V. Hansson. 1991. Down regulation of messenger ribonucleic acid and protein levels for estrogen receptors by phorbol ester and calcium in MCF-7 cells. Endocrinology. 129:339-344.
32. Saceda, M., C. Knabbe, R. Dickson, M. Lippman, D. Bronzert, R. Lindsey, M. Gottardis, and M. Martin. 1991. Post-transcriptional destabilization of estrogen receptor mRNA in MCF-7 cells by 12-0-tetradecanoylphorbol-13-acetate. J. Biol. Chem. 266:17809-17814.
33. Tzukerman, M., X. Zhang, and M. Pfahl. 1991. Inhibition of estrogen receptor activity by the tumor promoter 12-0-tetradecanoylphorbol-13-acetate: a molecular analysis. Mol. Endocrinol. 5:1983-1992.
34. Blobe, G., C. Sachs, W. Khan, D. Fabbro, S. Stabel, W. Wetsel, L. Obeid, R. Fine, and Y. Hannun. 1993. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. J. Biol. Chem. 268:658-664.
35. 2+ independent isoform of protein kinase C in epithelial tissues, in association with epithelial differentiation. Cell Growth & Differ. 4:167-175.
36. Yu, G., S. Ahmad, A. Aquino, C. Fairchild, J. Trepel, S. Ohno, K. Suzuki, T. Tsuruo, K. Cowan, and R. Glazer. 1991. Transection with protein kinase C-α confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun. 3:181-189.
37. Borner, C., I. Fillipuzzii, I. Weinstein, and R. Imber. 1991. Failure of wild-type or a mutant form of protein kinase C-α to transform fibroblasts. Nature (Lond.). 353:78-80.
38. Cacace, A., S. Guadango, R. Krauss, D. Fabbro, and I. Weinstein. 1993. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene. 8:2095-2014.
39. Frisch, S., and H. Francis. 1994. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124:619-625.
40. Obeid, L., G. Blobe, L. Karolak, and Y. Hannun. 1992. Cloning and characterization of the major promoter of the human protein kinase C β gene. J. Biol. Chem. 267:20804-20810.
41. Prendiville, J., D. Crowther, N. Thatcher, P. Woll, B. Fox, A. McGowan, N. Testa, P. Stern, R. McDermott, M. Potter, and G. Pettit. 1993. A phase one study of intravenous bryostatin 1 in patients with advanced cancer. Br. J. Cancer. 68:418-425.
42. Philip, P., D. Rea, P. Thavasu, J. Carmichael, N. Stuart, H. Rockett, D. Talbot, T. Ganesan, G. Pettit, F. Balkwill, and A. Harris. 1993. Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor α induction in vitro. J. Natl. Cancer Inst. 85:1812-1818.